FrancophonIA/ELRC3.0 huggingface dataset:
English: Half-life was prolonged from 1.3 hr to 3.7 hr, resulting in possibly enhanced and prolonged blood glucose-lowering effect of repaglinide, and plasma repaglinide concentration at 7 hr was increased 28.6-fold by gemfibrozil.
Slovenian: Pri sočasni uporabi gemfibrozila se je razpolovni čas z 1,3 ure podaljšal na 3,7 ure, kar bi lahko okrepilo in podaljšalo učinek repaglinida na znižanje vrednosti glukoze v krvi, koncentracija repaglinida v plazmi pa je bila po 7 urah 28,6-krat večja.
English: Name and address of the manufacturer responsible for batch release
Slovenian: Ime in naslov izdelovalca (izdelovalcev), odgovornega (odgovornih) za sproščanje serij
English: Do not take this medicine if you are under 18 years of age.
Slovenian: Otroci in mladostniki Bolniki, mlajši od 18 let, tega zdravila ne smejo jemati.
English: A small, significant decrease in blood glucose values was observed.
Slovenian: Prav tako so opazili majhno statistično značilno zmanjšanje koncentracije glukoze v krvi.
English: Enyglid is not recommended in patients with moderate liver disease.
Slovenian: Uporaba zdravila Enyglid pri bolnikih z zmerno boleznijo jeter ni priporočljiva.
English: If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Enyglid.
Slovenian: Če jemljete gemfibrozil (zdravilo za zdravljenje zvišane vrednosti maščob v krvi), zdravila Enyglid ne smete jemati.
English: Skin and subcutaneous tissue disorders
Slovenian: Bolezni kože in podkožja preobčutljivost*
English: Repaglinide metabolites are excreted primarily via the bile.
Slovenian: Presnovki repaglinida se v glavnem izločajo z žolčem.
English: Repaglinide should be used with caution or be avoided in patients receiving medicinal products which influence repaglinide metabolism (see section 4.5).
Slovenian: Pri bolnikih, ki se zdravijo z zdravili z vplivom na presnovo repaglinida, je treba repaglinid uporabljati previdno ali pa se njegovi uporabi izogniti (glejte poglavje 4.5).
English: β-blocking medicinal products may mask the symptoms of hypoglycaemia.
Slovenian: Zaviralci adrenergičnih receptorjev beta lahko prikrijejo simptome hipoglikemije.
English: • if you take other medicines or suffer from liver or kidney problems (see other sections of 2.
Slovenian: To se lahko zgodi: - če ste vzeli prevelik odmerek zdravila Enyglid, - če ste telesno bolj dejavni kot ponavadi, - če uporabljate druga zdravila ali imate težave z jetri ali ledvicami (glejte ostale dele poglavja 2.
English: No clinically relevant differences were seen in the pharmacokinetics of repaglinide, when repaglinide was administered 0, 15 or 30 minutes before a meal or in fasting state.
Slovenian: Pri uporabi repaglinida 0, 15 ali 30 minut pred obrokom ali na tešče niso opazili klinično pomembnih razlik v farmakokinetiki repaglinida.
English: Repaglinide should not be used in breast-feeding women.
Slovenian: Doječe matere repaglinida ne smejo uporabljati.
English: Plasma repaglinide levels decreased rapidly, and low concentrations were seen in the plasma of Type 2 diabetic patients 4 hours post-administration.
Slovenian: Nizko koncentracijo so v plazmi bolnikov s sladkorno boleznijo tipa 2 ugotovili 4 ure po uporabi.
English: Since the interaction has not been established with dosages higher than 0.25 mg for repaglinide, the concomitant use of ciclosporin with repaglinide should be avoided.
Slovenian: Ker to medsebojno delovanje ni ovrednoteno pri odmerkih, večjih od 0,25 mg repaglinida, se je treba sočasni uporabi ciklosporina in repaglinida izogibati.
English: A dose-dependent decrease in blood glucose was demonstrated in Type 2 diabetic patients when administered in doses from 0.5 to 4 mg repaglinide.
Slovenian: Pri bolnikih s sladkorno boleznijo tipa 2 so pri uporabi repaglinida v odmerkih od 0,5 do 4 mg dokazali od odmerka odvisno znižanje glukoze v krvi.
English: Your ability to drive or use a machine may be affected if your blood sugar is low or high.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Previsok ali prenizek krvni sladkor lahko vpliva na sposobnost upravljanja vozil in strojev.
English: A high interindividual variability (60%) in repaglinide plasma concentrations has been detected in the clinical trials.
Slovenian: V kliničnih preskušanjih so opazili močno variabilnost plazemskih koncentracij repaglinida med posameznimi bolniki (60 %).
English: Repaglinide, like other insulin secretagogues, is capable of producing hypoglycaemia.
Slovenian: Kot drugi sekretagogi inzulina lahko tudi repaglinid povzroči hipoglikemijo.
English: If you take too many tablets, your blood sugar may become too low, leading to a hypo.
Slovenian: Če ste vzeli večji odmerek zdravila Enyglid, kot bi smeli Če vzamete preveč tablet, se vam lahko krvni sladkor preveč zniža, kar lahko vodi do hipe.
English: Hepatic impairment No clinical studies have been conducted in patients with hepatic insufficiency.
Slovenian: Okvara jeter Pri bolnikih z jetrno insuficienco klinične študije niso bile izvedene.
English: Co-administration of 200 mg ketoconazole increased the repaglinide (AUC and Cmax) by 1.2-fold with profiles of blood glucose concentrations altered by less than 8% when administered concomitantly (a single dose of 4 mg repaglinide).
Slovenian: Pri sočasni uporabi ketokonazola v odmerku 200 mg sta se vrednosti AUC in Cmax repaglinida povečali za 1,2-krat, profil koncentracij glukoze v krvi pa se je spremenil za manj kot 8 %, če so osebe zdravili prejele sočasno (repaglinid v enkratnem odmerku 4 mg).
English: Refraction disorder*
Slovenian: Očesne bolezni okvare refrakcije*
English: In an interaction study with healthy volunteers, co-administration of deferasirox (30 mg/kg/day, 4 days), a moderate inhibitor of CYP2C8 and CYP3A4, and repaglinide (single dose, 0.5 mg) resulted in an increase in repaglinide systemic exposure (AUC) to 2.3-fold (90% CI [2.03-2.63]) of control, a 1.6-fold (90% CI [1.42-1.84]) increase in Cmax, and a small, significant decrease in blood glucose values.
Slovenian: V študiji medsebojnega delovanja z drugimi zdravili, izvedeni pri zdravih prostovoljcih, se je pri sočasni uporabi deferasiroksa (4 dni v odmerku 30 mg/kg/dan), ki je zmeren zaviralec tako CYP2C8 kot CYP3A4, ter repaglinida (enkratni odmerek 0,5 mg) sistemska izpostavljenost (AUC) repaglinidu povečala za 2,3-krat (90-odstotni interval zaupanja [2,03-2,63]) kontrolne vrednosti, vrednost Cmax povečala za 1,6-krat (90-odstotni interval zaupanja [1,42-1,84]), vrednost glukoze v krvi pa nekoliko pomembno zmanjšala.
English: Maintenance
Slovenian: Vzdrževanje
English: Enyglid 0.5 mg tablets Enyglid 1 mg tablets Enyglid 2 mg tablets
Slovenian: Enyglid 0,5 mg tablete Enyglid 1 mg tablete Enyglid 2 mg tablete
English: What Enyglid contains
Slovenian: Kaj vsebuje navodilo
English: How to take Enyglid
Slovenian: Kako jemati zdravilo Enyglid
English: The peak plasma level occurs within one hour post administration.
Slovenian: Največjo koncentracijo v plazmi doseže eno uro po zaužitju.
English: If the combination appears necessary, careful clinical and blood glucose monitoring should be performed (see section 4.4).
Slovenian: Če pa je uporaba te kombinacije nujna, sta potrebna natančen klinični nadzor in kontrola glukoze v krvi (glejte poglavje 4.4).
English: Enyglid 0.5 mg tablets Enyglid 1 mg tablets Enyglid 2 mg tablets Repaglinide
Slovenian: Enyglid 0,5 mg tablete Enyglid 1 mg tablete Enyglid 2 mg tablete repaglinid
English: Since the interaction has not been established with dosages higher than 0.5 mg for repaglinide, the concomitant use of deferasirox with repaglinide should be avoided.
Slovenian: Ker študije medsebojnega delovanja z repaglinidom v odmerkih, večjih od 0,5 mg, niso bile izvedene, se je treba sočasni uporabi deferasiroksa in repaglinida izogibati.
English: Each tablet contains 0.5 mg repaglinide.
Slovenian: Ena tableta vsebuje 0,5 mg repaglinida.
English: The resulting increased calcium influx induces insulin secretion from the β-cell.
Slovenian: Vtok kalcija se zato zveča in to sproži izločanje inzulina iz celic β.
English: Co-administration of cimetidine, nifedipine, oestrogen, or simvastatin with repaglinide, all CYP3A4 substrates, did not significantly alter the pharmacokinetic parameters of repaglinide.
Slovenian: Pri sočasni uporabi repaglinida in drugih učinkovin, ki se presnavljajo s CYP3A4, kot so cimetidin, nifedipin, estrogen ali simvastatin se farmakokinetične lastnosti repaglinida niso pomembneje spremenile.
English: Not known
Slovenian: neznana pogostnost
English: Enyglid 0.5 mg tablets Each tablet contains 0.5 mg repaglinide.
Slovenian: Enyglid 0,5 mg tablete Ena tableta vsebuje 0,5 mg repaglinida.
English: Your doctor will work out your dose.
Slovenian: Odmerek zdravila vam bo predpisal zdravnik.
English: Enyglid should be taken with caution.
Slovenian: V tem primeru morate zdravilo Enyglid uporabljati previdno.
English: At such times diabetic control may be lost.
Slovenian: V takšnih primerih lahko sladkorna bolezen postane neurejena.
English: The recommended starting dose is 0.5 mg. One to two weeks should elapse between titration steps (as determined by blood glucose response).
Slovenian: Med posameznimi prilagoditvami odmerka mora miniti teden ali dva (glede na odziv glukoze v krvi).
English: They include: increased urination, feeling thirsty, dry skin and dry mouth.
Slovenian: Opozorilni znaki previsokega krvnega sladkorja se pojavijo postopoma in vključujejo:.pogostejše uriniranje, občutek žeje, suho kožo in suha usta.
English: Each tablet contains 1 mg repaglinide.
Slovenian: Ena tableta vsebuje 1 mg repaglinida.
English: Repaglinide exposure is increased in patients with hepatic insufficiency and in the elderly type 2 diabetic patients.
Slovenian: Pri bolnikih z insuficienco jeter in starostnikih s sladkorno boleznijo tipa 2 je izpostavljenost repaglinidu povečana.
English: Enyglid 1 mg tablets Each tablet contains 1 mg repaglinide.
Slovenian: Enyglid 1 mg tablete Ena tableta vsebuje 1 mg repaglinida.
English: Special care should be taken when inhibitors of both CYP2C8 and 3A4 are coadministered simultaneously with repaglinide.
Slovenian: Posebna previdnost je potrebna v primeru sočasne uporabe repaglinida in zdravil, ki zavirajo tako CYP2C8 kot 3A4.
English: Enyglid 2 mg tablets Each tablet contains 2 mg repaglinide.
Slovenian: Enyglid 2 mg tablete Ena tableta vsebuje 2 mg repaglinida.
English: Enyglid 2 mg tablets
Slovenian: Enyglid 2 mg tablete repaglinid
English: • Hypersensitivity (such as rash, itchy skin, redening of the skin, swelling of the skin)
Slovenian: Neželeni učinki neznane pogostnosti - preobčutljivost (npr. izpuščaj, srbeča koža, pordelost kože, oteklost kože) - siljenje na bruhanje (navzeja)
English: If you get any side effects, talk to your doctor or pharmacist.
Slovenian: - Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom ali farmacevtom.
English: Enyglid 0.5 mg tablets
Slovenian: Enyglid 0,5 mg tablete repaglinid
English: Enyglid should not be taken if you have a severe liver disease (see Do not take Enyglid).
Slovenian: Bolniki s hudo boleznijo jeter pa zdravila Enyglid ne smejo jemati (glejte odstavek Ne jemljite zdravila Enyglid).
English: Abnormal hepatic function, increased liver enzymes*
Slovenian: Bolezni jeter, žolčnika in žolčevodov moteno delovanje jeter, zvišana vrednost jetrnih encimov*
English: Repaglinide is almost completely metabolised, and no metabolites with clinically relevant hypoglycaemic effect have been identified.
Slovenian: Presnovkov s klinično pomembnim hipoglikemičnim učinkom niso odkrili.
English: Enyglid 1 mg tablets
Slovenian: Enyglid 1 mg tablete repaglinid
English: In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of 0.25 mg) and ciclosporin (repeated dose at 100 mg) increased repaglinide AUC and Cmax about 2.5-fold and 1.8-fold respectively.
Slovenian: V študiji pri zdravih prostovoljcih se je pri sočasni uporabi repaglinida (enkratni 0,25-mg odmerek) in ciklosporina (ponavljajoči se 100-mg odmerki) vrednost AUC repaglinida povečala za približno 2,5krat, vrednost Cmax pa za približno 1,8-krat.
English: No such cases have led to discontinuation of repaglinide treatment in clinical trials.
Slovenian: V kliničnih preskušanjih v nobenem od takšnih primerov zdravljenja z repaglinidom ni bilo treba prekiniti.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed.
Slovenian: Če je sočasno jemanje teh dveh zdravil nujno, je treba pazljivo nadzirati vrednosti glukoze v krvi in bolnika natančno klinično spremljati..
English: Co-administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC 8.1-fold and Cmax 2.4-fold in healthy volunteers.
Slovenian: Pri sočasni uporabi gemfibrozila (v odmerku 600 mg dvakrat na dan), zaviralca CYP2C8, in repaglinida (v enkratnem odmerku 0,25-mg) se je pri zdravih prostovoljcih vrednost AUC repaglinida povečala za 8,1-krat, vrednost Cmax pa za 2,4-krat.
English: Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC, Cmax and t½ (1.6-fold, 1.4-fold and 1.2-fold respectively) with no statistically significant effects on the blood glucose levels.
Slovenian: Pri sočasni uporabi trimetoprima (v odmerku160 mg dvakrat na dan), srednje močnega zaviralca CYP2C8, in repaglinida (v enkratnem odmerku 0,25-mg) se je vrednost AUC repaglinida povečala, za 1,6-krat, vrednost Cmax za 1,4-krat,vrednost t1/2 pa za 1,2-krat, brez statistično pomembnega vpliva na vrednosti glukoze v krvi.
English: Be aware that the desired effect is not achieved if you stop taking Enyglid.
Slovenian: Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed (see section 4.4).
Slovenian: Če je sočasna uporaba obeh zdravil nujna, je treba skrbno nadzirati vrednosti glukoze v krvi in bolnika natančno klinično spremljati (glejte poglavje 4.4).
English: Allergic reactions*
Slovenian: Bolezni imunskega sistema alergijske reakcije*
English: Yellow iron oxide (E172) - only in 1 mg tablets Red iron oxide (E172) - only in 2 mg tablets
Slovenian: 6.1 Seznam pomožnih snovi mikrokristalna celuloza (E460) brezvodni kalcijev hidrogenfosfat premreženi natrijev karmelozat povidon K25 glicerol magnezijev stearat meglumin polokasmer rumeni železov oksid (E172) - samo v 1-mg tabletah rdeči železov oksid (E172) - samo v 2-mg tabletah
English: It has not been studied in these age groups.
Slovenian: Uporaba zdravila Enyglid ni priporočljiva, saj njegova uporaba v teh starostnih skupinah ni bila raziskana.
English: Consequently metabolism, and by that clearance of repaglinide, may be altered by substances which influence these cytochrome P-450 enzymes via inhibition or induction.
Slovenian: V primeru uporabe učinkovin, ki vplivajo na ta encima citokroma P-450, bodisi z inhibicijo bodisi z indukcijo, se presnova in s tem tudi očistek repaglinida lahko spremeni.
English: The advisability of driving should be considered in these circumstances.
Slovenian: V takšnih okoliščinah je treba presoditi, če je sploh priporočljivo, da bolnik vozi.
English: What Enyglid looks like and contents of the pack The 0.5 mg tablets are white, round and biconvex with bevelled edges.
Slovenian: Enyglid 0,5 mg tablete Tablete so bele, okrogle in izbočene, s posnetim robom.
English: After a 5 day treatment of repaglinide (2 mg x 3/day) in patients with a severe impaired renal function (creatinine clearance: 20-39 ml/min.
Slovenian: Pri bolnikih s hudo okvaro ledvičnega delovanja (očistek kreatinina 20-39 ml/min) so rezultati po 5dnevnem zdravljenju z repaglinidom (2 mg 3-krat na dan) pokazali pomembno 2-kratno zvečanje izpostavljenosti (AUC) in razpolovnega časa (t1/2) v primerjavi z bolniki z normalnim ledvičnim delovanjem.
English: However, the benefit risk profile remains to be established when comparing to other combination therapies.
Slovenian: Preskušanja s kombiniranim zdravljenjem z inzulinom NPH ali s tiazolidindioni so bila izvedena, vendar pa je treba profil koristi in tveganj v primerjavi z drugimi kombiniranimi zdravljenji še ugotoviti.
English: In an interaction study with healthy volunteers, co-administration of clopidogrel (300 mg loading dose), a CYP2C8 inhibitor, increased repaglinide exposure (AUC0-∞) 5.1-fold and continued administration (75 mg daily dose) increased repaglinide exposure (AUC0-∞) 3.9-fold.
Slovenian: V študiji medsebojnega delovanja z drugimi zdravili, izvedeni pri zdravih prostovoljcih, se je pri sočasni uporabi klopidogrela (zaviralec CYP2C8) sistemska izpostavljenost repaglinidu (AUC0-∞) povečala 5,1-krat, če so uporabili začetni odmerek 300 mg klopidogrela, ter 3,9-krat pri nadaljnji uporabi 75 mg klopidogrela na dan.
English: Hypoglycaemic coma and hypoglycaemic unconsciousness
Slovenian: Presnovne in prehranske motnje hipoglikemija pogosti hipoglikemična koma in hipoglikemična nezavest neznana pogostnost
English: When a patient stabilised on any oral hypoglycaemic medicinal product is exposed to stress such as fever, trauma, infection or surgery, a loss of glycaemic control may occur.
Slovenian: Dejavniki stresa, kot so zvišana telesna temperatura, poškodba, okužba ali kirurški poseg, lahko pri bolnikih, katerih stanje je pri uporabi peroralnega antidiabetika stabilno, povzročijo izgubo urejenosti glikemije.
English: Tabulated list of adverse reactions
Slovenian: Tabelarni pregled neželenih učinkov
English: How to store Enyglid
Slovenian: Shranjevanje zdravila Enyglid
English: Magnesium stearate
Slovenian: PRETISNI OMOT
English: Meglumine
Slovenian: Dojenje
English: Adjustment of dose and adherence to diet and exercise should be assessed before classifying a patient as a secondary failure.
Slovenian: Preden stanje opredelimo kot sekundarno odpoved, je treba preveriti, ali je odmerek uravnan in ali se bolnik drži diete in telesne dejavnosti.
English: The 2 mg tablets are pink, marbled, round, biconvex with bevelled edges and possible darker spots.
Slovenian: 2-mg tablete so roza, marmorirane, okrogle, izbočene, s posnetim robom in z možnimi temnejšimi pikami.
English: In an interaction study in healthy volunteers, co-administration of 250 mg clarithromycin, a potent mechanism-based inhibitor of CYP3A4, slightly increased the repaglinide (AUC) by 1.4-fold and Cmax by 1.7-fold and increased the mean incremental AUC of serum insulin by 1.5-fold and the maximum concentration by 1.6-fold.
Slovenian: V študiji medsebojnega delovanja z drugimi zdravili, izvedeni pri zdravih prostovoljcih, se je pri sočasni uporabi klaritromicina v odmerku 250 mg, ki močno zavira encimski mehanizem CYP3A4, vrednost AUC repaglinida zvečala za 1,4-krat, vrednost Cmax pa za 1,7-krat.
English: Each tablet contains 2 mg repaglinide.
Slovenian: Ena tableta vsebuje2 mg repaglinida.
English: Refraction disorders
Slovenian: Okvare refrakcije
English: Enyglid 2 mg tablets The tablets are pink, marbled, round, biconvex with bevelled edges and possible darker spots.
Slovenian: Enyglid 2 mg tablete Tablete so roza, marmorirane, okrogle, izbočene, s posnetim robom in z možnimi temnejšimi pikami.
English: Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β-cells in the pancreatic islets.
Slovenian: Ta učinek je odvisen od obstoja delujočih celic β v pankreasnih otočkih.
English: You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low.
Slovenian: Če se vam krvni sladkor prekomerno zniža, lahko doživite hipo (hipa je okrajšava za hipoglikemijo in pomeni simptome nizkega krvnega sladkorja).
English: There are no studies in breast-feeding women.
Slovenian: Študije o uporabi repaglinida pri doječih materah niso bile izvedene.
English: Enyglid 2 mg tablets 30 tablets: EU/1/09/580/013 60 tablets: EU/1/09/580/014 90 tablets: EU/1/09/580/015 120 tablets: EU/1/09/580/016 180 tablets: EU/1/09/580/021 270 tablets: EU/1/09/580/017 360 tablets: EU/1/09/580/018
Slovenian: Enyglid 2 mg tablete 30 tablet: EU/1/09/580/013 60 tablet: EU/1/09/580/014 90 tablet: EU/1/09/580/015 120 tablet: EU/1/09/580/016 180 tablet: EU/1/09/580/021 270 tablet: EU/1/09/580/017 360 tablet: EU/1/09/580/018
English: Co-administration of 100 mg itraconazole, an inhibitor of CYP3A4, has also been studied in healthy volunteers, and increased the AUC by 1.4-fold.
Slovenian: Pri zdravih prostovoljcih so raziskovali tudi sočasno uporabo itrakonazola v odmerku 100 mg, ki je zaviralec CYP3A4.
English: Enyglid 1 mg tablets The tablets are pale brown-yellow, round, biconvex with bevelled edges and possible darker spots.
Slovenian: Enyglid 1 mg tablete Tablete so bledo rjavo-rumene, okrogle, izbočene, s posnetim robom in z možnimi temnejšimi pikami.
English: 60 tablets: EU/1/09/580/014
Slovenian: 60 tablet: EU/1/09/580/014
English: Enyglid is not recommended.
Slovenian: Navedba smiselno ni potrebna.
English: 30 tablets: EU/1/09/580/013
Slovenian: 30 tablet: EU/1/09/580/013
English: Repaglinide is .
Slovenian: - Navodilo shranite.
English: Enyglid 1 mg tablets 30 tablets: EU/1/09/580/007 60 tablets: EU/1/09/580/008 90 tablets: EU/1/09/580/009 120 tablets: EU/1/09/580/010 180 tablets: EU/1/09/580/020 270 tablets: EU/1/09/580/011 360 tablets: EU/1/09/580/012
Slovenian: Enyglid 1 mg tablete 30 tablet: EU/1/09/580/007 60 tablet: EU/1/09/580/008 90 tablet: EU/1/09/580/009 120 tablet: EU/1/09/580/010 180 tablet: EU/1/09/580/020 270 tablet: EU/1/09/580/011 360 tablet: EU/1/09/580/012
English: Common (may affect up to 1 in 10 people):
Slovenian: Pogosti (pojavijo se lahko pri največ 1 od 10 bolnikov) - bolečina v trebuhu - driska
English: 120 tablets: EU/1/09/580/004 180 tablets: EU/1/09/580/019 270 tablets: EU/1/09/580/005 360 tablets: EU/1/09/580/006
Slovenian: 120 tablet: EU/1/09/580/004 180 tablet: EU/1/09/580/019 270 tablet: EU/1/09/580/005 360 tablet: EU/1/09/580/006
English: 90 tablets: EU/1/09/580/015
Slovenian: 90 tablet: EU/1/09/580/015
English: • Keep this leaflet.
Slovenian: Glejte poglavje
English: 30 tablets: EU/1/09/580/007
Slovenian: 30 tablet: EU/1/09/580/007
English: 120 tablets: EU/1/09/580/016 180 tablets: EU/1/09/580/021 270 tablets: EU/1/09/580/017 360 tablets: EU/1/09/580/018
Slovenian: 120 tablet: EU/1/09/580/016 180 tablet: EU/1/09/580/021 270 tablet: EU/1/09/580/017 360 tablet: EU/1/09/580/018
English: QUALIA PHARMA S.A. Τηλ: + 30 (0) 210 2832941
Slovenian: ELOGIS PHARMA S.A. Τηλ: + 30 210 6254175
English: 120 tablets: EU/1/09/580/010 180 tablets: EU/1/09/580/020 270 tablets: EU/1/09/580/011 360 tablets: EU/1/09/580/012
Slovenian: 120 tablet: EU/1/09/580/010 180 tablet: EU/1/09/580/020 270 tablet: EU/1/09/580/011 360 tablet: EU/1/09/580/012
English: 60 tablets: EU/1/09/580/002
Slovenian: 60 tablet: EU/1/09/580/002
English: 30 tablets: EU/1/09/580/001
Slovenian: 30 tablet: EU/1/09/580/001
English: 60 tablets: EU/1/09/580/008
Slovenian: 60 tablet: EU/1/09/580/008
English: 90 tablets: EU/1/09/580/003
Slovenian: 90 tablet: EU/1/09/580/003
English: Abdominal pain, diarrhoea Common Vomiting, constipation
Slovenian: Bolezni prebavil bolečina v trebuhu, driska pogosti bruhanje, zaprtost zelo redki navzea neznana pogostnost
English: 90 tablets: EU/1/09/580/009
Slovenian: 90 tablet: EU/1/09/580/009
English: Check with your doctor if you are not sure.
Slovenian: Če ste negotovi, se posvetujte z zdravnikom.
English: The 1 mg tablets are pale brown-yellow, round, biconvex with bevelled edges and possible darker spots.
Slovenian: 1-mg tablete so bledo rjavo-rumene, okrogle, izbočene, s posnetim robom in z možnimi temnejšimi pikami.
English: The tablets are white, round and biconvex with bevelled edges.
Slovenian: 0,5-mg tablete so bele, okrogle in izbočene, s posnetim robom.
English: • The active substance is repaglinide.
Slovenian: Repaglinid se skoraj v celoti presnovi.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Slovenian: Izgled zdravila Enyglid in vsebina pakiranja